Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study.
Eur Urol Open Sci. 2022 Apr 26;40:38-45. doi: 10.1016/j.euros.2022.03.012. eCollection 2022 Jun.
Eur Urol Open Sci. 2022.
PMID: 35638086
Free PMC article.
Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial.
Smith MR, Scher HI, Sandhu S, Efstathiou E, Lara PN Jr, Yu EY, George DJ, Chi KN, Saad F, Ståhl O, Olmos D, Danila DC, Mason GE, Espina BM, Zhao X, Urtishak KA, Francis P, Lopez-Gitlitz A, Fizazi K; GALAHAD investigators.
Smith MR, et al.
Lancet Oncol. 2022 Mar;23(3):362-373. doi: 10.1016/S1470-2045(21)00757-9. Epub 2022 Feb 4.
Lancet Oncol. 2022.
PMID: 35131040
Free PMC article.
Clinical Trial.
Item in Clipboard
Effect of docetaxel added to bicalutamide in Hormone-Naïve non-metastatic prostate cancer with rising PSA, a randomized clinical trial (SPCG-14).
Josefsson A, Jellvert Å, Holmberg E, Brasso K, Meidahl Petersen P, Aaltomaa S, Luukkaa M, Verhagen P, de Wit R, Ahlgren G, Andrén O, Castellanos E, Seke M, Widmark A, Damber JE; SPCG14-investigators.
Josefsson A, et al. Among authors: jellvert a.
Acta Oncol. 2023 Apr;62(4):372-380. doi: 10.1080/0284186X.2023.2199940. Epub 2023 Apr 19.
Acta Oncol. 2023.
PMID: 37073813
Clinical Trial.
Item in Clipboard
Effective oral combination metronomic chemotherapy with low toxicity for the management of castration-resistant prostate cancer.
Jellvert A, Lissbrant IF, Edgren M, Ovferholm E, Braide K, Olvenmark AM, Kindblom J, Albertsson P, Lennernäs B.
Jellvert A, et al.
Exp Ther Med. 2011 Jul;2(4):579-584. doi: 10.3892/etm.2011.272. Epub 2011 May 12.
Exp Ther Med. 2011.
PMID: 22977543
Free PMC article.
Item in Clipboard
Castration is a prerequisite for the inhibitory effect of metronomic chemotherapy on the growth of experimental castration-resistant prostate cancer.
Jellvert Å, Åhs D, Olausson J, Franck Lissbrant I, Damber JE, Welén K.
Jellvert Å, et al.
Acta Oncol. 2018 Jul;57(7):895-901. doi: 10.1080/0284186X.2017.1423178. Epub 2018 Jan 4.
Acta Oncol. 2018.
PMID: 29299975
Item in Clipboard
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma.
Motzer RJ, Escudier B, McDermott DF, George S, Hammers HJ, Srinivas S, Tykodi SS, Sosman JA, Procopio G, Plimack ER, Castellano D, Choueiri TK, Gurney H, Donskov F, Bono P, Wagstaff J, Gauler TC, Ueda T, Tomita Y, Schutz FA, Kollmannsberger C, Larkin J, Ravaud A, Simon JS, Xu LA, Waxman IM, Sharma P; CheckMate 025 Investigators.
Motzer RJ, et al.
N Engl J Med. 2015 Nov 5;373(19):1803-13. doi: 10.1056/NEJMoa1510665. Epub 2015 Sep 25.
N Engl J Med. 2015.
PMID: 26406148
Free PMC article.
Clinical Trial.
Item in Clipboard
Impact of quality indicators on adherence to National and European guidelines for renal cell carcinoma.
Thorstenson A, Harmenberg U, Lindblad P, Ljungberg B, Lundstam S; Swedish Kidney Cancer Quality Register Group.
Thorstenson A, et al.
Scand J Urol. 2016;50(1):2-8. doi: 10.3109/21681805.2015.1059882. Epub 2015 Jul 23.
Scand J Urol. 2016.
PMID: 26202573
Item in Clipboard
Cite
Cite